Nathan Rich

Stock Analyst at Goldman Sachs

(0)
# 4268
Out of 5,240 analysts
96
Total ratings
36.36%
Success rate
-9.04%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Oscar Health
Maintains: Neutral
16 21
14.96 40.37% 6 May 9, 2024
Zoetis
Maintains: Buy
223 196
164.36 19.25% 8 May 6, 2024
Dentsply Sirona
Maintains: Neutral
34 30
18.02 66.48% 8 May 6, 2024
Amneal Pharmaceutica...
Maintains: Strong Buy
7 8
7.86 1.78% 7 May 6, 2024
Envista Holdings
Maintains: Sell
20 18
18.86 -7.21% 4 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 385
282.58 36.24% 7 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
13 14
11.69 19.76% 9 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
21 -47.62% 4 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
197 225
210.51 6.88% 2 Feb 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
500 650
418.22 55.42% 3 Jan 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
35 30
30.89 -2.88% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 300
2.76 10769.57% 8 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 88
51.58 70.61% 6 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
13.47 -10.91% 6 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
93 85
71.25 19.3% 1 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
18 16
n/a n/a 1 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
11.71 -6.06% 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 240
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
335
294.24 13.85% 1 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
535
543.03 -1.48% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
10
n/a n/a 1 Dec 18, 2019